5299 篇
13868 篇
408780 篇
16079 篇
9269 篇
3869 篇
6464 篇
1238 篇
72401 篇
37108 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4867 篇
3821 篇
5293 篇
全球基因组学和蛋白组学分析仪器市场报告(2014-2018年)
Global Genomics and Proteomics Analytical Instruments Market 2014-2018
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
07.1 Global Chromatography Instruments Market
07.1.1 Market Size and Forecast
07.2 Global PCR Instruments Market
07.2.1 Market Size and Forecast
07.3 Global MS Instruments Market
07.3.1 Market Size and Forecast
07.4 Global NGS Instruments Market
07.4.1 Market Size and Forecast
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2013
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Agilent Technologies
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation
17.1.4 Sales Segmentation
17.1.5 Business Strategy
17.1.6 Key Information
17.1.7 SWOT Analysis
17.1.8 Strengths
17.1.9 Weaknesses
17.1.10 Opportunities
17.1.11 Threats
17.2 Bio-Rad Laboratories
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation
17.2.4 Business Segmentation by Revenue 2012 and 2011
17.2.5 Geographical Segmentation
17.2.6 Business Strategy
17.2.7 Key Information
17.2.8 SWOT Analysis
17.2.9 Strengths
17.2.10 Weaknesses
17.2.11 Opportunities
17.2.12 Threats
17.3 F. Hoffmann-La Roche
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation
17.3.4 Sales Segmentation
17.3.5 Business Strategy
17.3.6 Key Information
17.3.7 SWOT Analysis
17.3.8 Strengths
17.3.9 Weaknesses
17.3.10 Opportunities
17.3.11 Threats
17.4 Illumina
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation
17.4.4 Sales Segmentation
17.4.5 Business Strategy
17.4.6 Key Information
17.4.7 SWOT Analysis
17.4.8 Strengths
17.4.9 Weaknesses
17.4.10 Opportunities
17.4.11 Threats
17.5 PerkinElmer
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation by Revenue 2013
17.5.4 Business Segmentation by Revenue 2012 and 2013
17.5.5 Business Strategy
17.5.6 Key Information
17.5.7 SWOT Analysis
17.5.8 Strengths
17.5.9 Weaknesses
17.5.10 Opportunities
17.5.11 Threats
17.6 Thermo Fisher Scientific
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Segmentation
17.6.4 Product Segmentation by Revenue
17.6.5 Sales Segmentation
17.6.6 Business Strategy
17.6.7 Key Information
17.6.8 SWOT Analysis
17.6.9 Strengths
17.6.10 Weaknesses
17.6.11 Opportunities
17.6.12 Threats
18. Other Reports in this Series